High Tower Advisors, LLC Cocrystal Pharma, Inc. Transaction History

High Tower Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$0.65 - $1.02 $40,950 - $64,261	-63,001 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.01 - $1.25 $28,280 - $35,000	-28,000 Reduced 30.77%	63,001 $66,000
Q2 2021 Aug 06, 2021	BUY	$1.08 - $2.14 $59,400 - $117,700	55,000 Added 152.77%	91,001 $114,000
Q1 2021 May 10, 2021	BUY	$1.3 - $2.35 $6,371 - $11,517	4,901 Added 15.76%	36,001 $50,000
Q4 2020 Feb 10, 2021	BUY	$0.8 - $2.16 $24,880 - $67,176	31,100 New	31,100 $42,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.